Legal & General Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Legal & General Group’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,477	Closed	-$1.12M	–	3435
2024 Q3	$1.12M	Buy	33,477 +6,200	+23%	+$213K	﹤0.01%	2197
2024 Q2	$737K	Buy	27,277 +6,816	+33%	+$134K	﹤0.01%	2293
2024 Q1	$442K	Buy	20,461 +18,791	+1,125%	+$410K	﹤0.01%	2475
2023 Q4	$10.1K	Hold	1,670	–	–	﹤0.01%	3235
2023 Q3	$9.29K	Hold	1,670	–	–	﹤0.01%	3281
2023 Q2	$12.3K	Buy	+1,670	New	+$12.6K	﹤0.01%	3279

Legal & General Group's LBPH Position: Q4 2024 in Review

Legal & General Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 33,477 shares — an estimated $1.12M sold.

Legal & General Group first reported a position in LBPH in Q2 2023 and held it in 6 quarters. The position peaked at $1.12M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Legal & General Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Legal & General Group sold 33,477 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.12M.
Legal & General Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
Legal & General Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.12M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Legal & General Group's 13F filing for Q4 2024, filed 13 Feb 2025.